Table 3.
Clinical and hematologic characteristics of patients with ES according to death occurrence
| Alive (n = 93) |
Dead (n = 23) |
|
|---|---|---|
| Demographics | ||
| Age, y | 46.7 (1.9-84.6) | 71.4 (18.3-94.8)* |
| Sex | ||
| Male | 45 (48) | 11 (48) |
| Female | 48 (52) | 12 (52) |
| Laboratory values | ||
| Hb, g/dL | 8.9 (2.8-17.0) | 6.6 (3.0-13.3)** |
| PLTs, × 109/L | 19 (1-564) | 39 (2-727) |
| ANC, × 109/L | 2.50 (0.2-15.2) | 3.1 (0.25-9.0) |
| LDH, ×ULN | 1.6 (0.52-11.11) | 2 (1-16) |
| IgG, g/dL | 955 (52-5660) | 1052 (340-1618) |
| IgA, g/dL | 143 (24-1257) | 165 (65-260) |
| IgM, g/dL | 95 (10-1800) | 82 (39-218) |
| DAT+ | 82 (88) | 21 (91) |
| IgG | 53 (65) | 11 (52) |
| IgG + C | 20 (24) | 5 (24) |
| C | 5 (6) | 0 (0) |
| Mixed | 4 (5) | 3 (14)*** |
| Atypical | // | 2 (10)*** |
| Positive antiplatelets (n = 38) | 32 (84) | 9 (82) |
| Positive antineutrophils (n = 22) | 10 (45) | 1 (20) |
| Complications | ||
| Infection | 27 (29) | 12 (52) |
| Thrombosis | 18 (19) | 7 (30) |
Demographics and laboratory data reflect those collected at disease onset. Values are given as median (range) or n (%).
LDH, lactate dehydrogenase; ULN, upper limit of normal.
*
P = .001, **P < .05, ***P = .01.